Hizentra® PID

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conference and Events	Key Publications

Key Publications

Efficacy and Safety of a new 20% Immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with Primary Immunodeficiency

Hagan, JB et al
J Clin Immunol
Request | Ask a Question | View Article

Efficacy and safety of Hizentra in patients with Primary Immunodeficiency after a dose-equivalent switch from IV or SC replacement therapy

Jolles, S et al
Clinical Immunology, 2011
Request | Ask a Question | View Article

Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with Primary Immunodeficiency Diseases

Kanegane, H et al
J Clin Immunol, 2013
Request | Ask a Question | View Article

Long-Term efficacy, safety and tolerability of Hizentra for treatment of Primary Immunodeficiency Disease

Jolles, S et al
Clinical Immunology, 2013
Request | Ask a Question | View Article